Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine. [electronic resource]
Producer: 20140218Description: 644-54 p. digitalISSN:- 1557-7422
- Adaptive Immunity -- immunology
- Adenocarcinoma -- genetics
- Analysis of Variance
- Animals
- Chlorocebus aethiops
- Colonic Neoplasms -- genetics
- Enzyme-Linked Immunospot Assay
- Genetic Engineering -- methods
- Granulocyte-Macrophage Colony-Stimulating Factor -- genetics
- Immunohistochemistry
- L-Lactate Dehydrogenase -- metabolism
- Measles virus -- genetics
- Mice
- Oncolytic Virotherapy -- methods
- Oncolytic Viruses -- genetics
- Vero Cells
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.